Home - Biotech Today

Digital diabetes treatment developer Better Therapeutics to go public in SPAC deal

Biotechnology Today April 12, 2021 By News Team
J&J Vision taps Menicon for contact lenses to slow childhood nearsightedness

Biotechnology Today April 12, 2021 By News Team
Donisi scores FDA clearance for contactless AI system that spots changes in heart, breathing patterns

Biotechnology Today April 12, 2021 By News Team

Transplant surgeons blaze a new trail with first trachea swap at Mount Sinai

Biotechnology Today April 12, 2021 By News Team

CytoDyn’s chief scientific officer Rahman quietly exits amid leronlimab limbo

Bio Space April 12, 2021 By News Team

In-demand virtual trial firm Medable nabs Duke University’s Tenaerts as CSO

Bio Space April 12, 2021 By News Team

In The News

Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. biotech-today.com is a wholly-owned subsidiary of Maynard Communication Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Digital diabetes treatment developer Better Therapeutics to go public in SPAC deal

J&J Vision taps Menicon for contact lenses to slow childhood nearsightedness

Donisi scores FDA clearance for contactless AI system that spots changes in heart, breathing patterns

Transplant surgeons blaze a new trail with first trachea swap at Mount Sinai

CytoDyn’s chief scientific officer Rahman quietly exits amid leronlimab limbo

In-demand virtual trial firm Medable nabs Duke University’s Tenaerts as CSO

In The News

Biotechnology Today

Digital diabetes treatment developer Better Therapeutics to go public in SPAC deal

J&J Vision taps Menicon for contact lenses to slow childhood nearsightedness

Donisi scores FDA clearance for contactless AI system that spots changes in heart, breathing patterns

Transplant surgeons blaze a new trail with first trachea swap at Mount Sinai

Pear Therapeutics to take digital treatments physical with sensor, activity tracker deals

Markets

Weekly Market Review – April 10, 2021

Weekly Market Review – April 3, 2021

Weekly Market Review – March 27, 2021

Weekly Market Review – March 20, 2021

Weekly Market Review – March 13, 2021

Bio Space

CytoDyn’s chief scientific officer Rahman quietly exits amid leronlimab limbo

In-demand virtual trial firm Medable nabs Duke University’s Tenaerts as CSO

Mission Bio, poised for growth, snags Thermo Fisher veteran Zhang as new CEO

Global News

SpaceX Starlink wins permit to send internet to customers like you

Facebook video calls soar 1000% during Italy’s lockdown

WeWork board’s special committee is demanding that SoftBank follow through with investment